Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HEICO Corp Class A
HEI.A
|
+$966M |
| 2 |
Verizon
VZ
|
+$445M |
| 3 |
ExxonMobil
XOM
|
+$409M |
| 4 |
Cencora
COR
|
+$269M |
| 5 |
ZTO Express
ZTO
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$341M |
| 2 |
Avantor
AVTR
|
+$318M |
| 3 |
CDK
CDK Global, Inc.
CDK
|
+$253M |
| 4 |
Salesforce
CRM
|
+$249M |
| 5 |
HCA Healthcare
HCA
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.16% |
| 2 | Healthcare | 13.37% |
| 3 | Financials | 12.68% |
| 4 | Industrials | 10.6% |
| 5 | Consumer Discretionary | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
Lexicon Pharmaceuticals
LXRX
$1.03B
| $53K | ﹤0.01% |
28,523
-1,326
| -4% | -$2.53K |
|
|
SLAI
3827
DELISTED
SOLAI Ltd ADS
SLAI
| $52K | ﹤0.01% |
1,187
-770
| -39% | -$96.3K |
|
3828
Invivyd
IVVD
$159M
| $52K | ﹤0.01% |
+16,001
| New | +$50.2K |
|
3829
Local Bounti
LOCL
$24.2M
| $52K | ﹤0.01% |
+1,254
| New | +$92.4K |
|
3830
Nautilus Biotechnolgy
NAUT
$124M
| $52K | ﹤0.01% |
+19,408
| New | +$72.2K |
|
3831
Celularity
CELU
$18.6M
| $50K | ﹤0.01% |
+1,472
| New | +$120K |
|
3832
AEye
LIDR
$52.8M
| $50K | ﹤0.01% |
+860
| New | +$116K |
|
3833
PolyPid
PYPD
$81.3M
| $50K | ﹤0.01% |
356
-675
| -65% | -$101K |
|
|
FXLV
3834
DELISTED
F45 Training Holdings Inc.
FXLV
| $50K | ﹤0.01% |
+12,638
| New | +$92.4K |
|
|
IRNT
3835
DELISTED
IronNet, Inc.
IRNT
| $50K | ﹤0.01% |
+22,677
| New | +$64K |
|
|
NUTX
3836
Nutex Health
NUTX
$1.03B
| $48K | ﹤0.01% |
+100
| New | +$118K |
|
3837
P3 Health Partners
PIII
$33.3M
| $48K | ﹤0.01% |
+257
| New | +$71.6K |
|
|
KLRS
3838
Kalaris Therapeutics
KLRS
$82.1M
| $48K | ﹤0.01% |
529
-107
| -17% | -$11.2K |
|
|
VLD
3839
DELISTED
Velo3D, Inc.
VLD
| $48K | ﹤0.01% |
+969
| New | +$113K |
|
|
BBLN
3840
DELISTED
Babylon Holdings Limited
BBLN
| $48K | ﹤0.01% |
+1,976
| New | +$86.2K |
|
|
GPUS
3841
Hyperscale Data Inc
GPUS
$55.2M
| $46K | ﹤0.01% |
1
| – | – |
|
|
CTV
3842
DELISTED
Innovid Corp.
CTV
| $46K | ﹤0.01% |
+27,125
| New | +$117K |
|
|
BOXD
3843
DELISTED
Boxed, Inc.
BOXD
| $46K | ﹤0.01% |
+25,503
| New | +$197K |
|
3844
MarketWise
MKTW
$53.7M
| $45K | ﹤0.01% |
+628
| New | +$43.6K |
|
3845
Nerdy
NRDY
$105M
| $45K | ﹤0.01% |
+21,350
| New | +$69.5K |
|
3846
OppFi
OPFI
$801M
| $45K | ﹤0.01% |
+13,563
| New | +$43.7K |
|
3847
Spire Global
SPIR
$440M
| $45K | ﹤0.01% |
+4,836
| New | +$62K |
|
|
LVOX
3848
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
| $45K | ﹤0.01% |
+27,349
| New | +$67.4K |
|
|
LTCH
3849
DELISTED
Latch, Inc. Common Stock
LTCH
| $45K | ﹤0.01% |
+39,495
| New | +$101K |
|
3850
BARK
BARK
$81.6M
| $44K | ﹤0.01% |
+1,715
| New | +$86.5K |
|
Similar funds
Invesco's Q2 2022 Portfolio in Review
As of Q2 2022, Invesco held 4,260 positions worth $330B, down 16% from $392B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Invesco's Q2 2022 filing shows 250 new, 2,115 increased, 1,487 reduced and 228 closed positions. Its largest new stake was Heliogen, Inc.: 258,718 shares worth $19.1M. The largest sale was Qualcomm, an estimated $341M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Invesco's largest Q2 2022 buy was Heliogen, Inc.: 258,718 shares worth $19.1M.
- Invesco added most to HEICO Corp Class A in Q2 2022, an estimated $966M increase.
- Invesco's biggest Q2 2022 reduction was Qualcomm, cutting an estimated $341M.
- Invesco fully exited Cerner Corp in Q2 2022, selling an estimated $153M.
- Invesco's ten largest holdings make up 11% of its $330B portfolio in Q2 2022.
- Invesco opened 250 new positions and closed 228 in Q2 2022.
- Invesco's portfolio value fell 16% quarter-over-quarter to $330B.
Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.